Literature DB >> 1363371

Pancreaticogastrostomy after pancreatoduodenectomy.

A Sauvanet1, J Belghiti, Y Panis, B Gayet, E Camara, G Urrejola, F Fékété.   

Abstract

The aim of this study was to evaluate the place of pancreaticogastrostomy (PG) in reducing pancreatic fistula after pancreatoduodenectomy. From January 1988 to June 1991, 32 consecutive patients (mean age, 57 years) were operated on, 25 for malignant disease (78%). The pancreatic remnant was normal in 17 patients (53%) and sclerotic in the others. There was one operative death (3.1%) unrelated to PG. Post-operative complications occurred in five patients (16%). Only two complications were related to PG: 1 patient had anastomotic intra-gastric bleeding and was reoperated on, 1 patient with a normal pancreatic remnant developed a pancreatic fistula (3.1%) treated conservatively. Reported series of PG, as well as our results, demonstrates that PG is associated with a dramatic decrease of both pancreatic fistula and mortality rates. The risk of anastomotic haemorrhage can be reduced by preventative ligation of submucosal gastric vessels. In conclusion, PG appears as a simple and reliable method of management of the pancreatic remnant after pancreatoduodenectomy.

Entities:  

Mesh:

Year:  1992        PMID: 1363371      PMCID: PMC2443019          DOI: 10.1155/1992/96487

Source DB:  PubMed          Journal:  HPB Surg        ISSN: 0894-8569


  3 in total

1.  Pancreatoduodenectomy with preservation of the pylorus and gastroduodenal artery.

Authors:  H Nagai; J Ohki; Y Kondo; T Yasuda; K Kasahara; K Kanazawa
Journal:  Ann Surg       Date:  1996-02       Impact factor: 12.969

2.  Pancreatic fistula after pancreatectomy: definitions, risk factors, preventive measures, and management-review.

Authors:  Norman Oneil Machado
Journal:  Int J Surg Oncol       Date:  2012-04-24

3.  Comparison of clinical outcomes between mesh-reinforced pancreatojejunostomy and pancreatogastrostomy following pancreaticoduodenectomy: a cohort study.

Authors:  Junhai Pan; Xiaolong Ge; Wei Zhou; Xin Zhong; Lihu Gu; Hepan Zhu; Xinlong Li; Weilin Qi; Xianfa Wang
Journal:  World J Surg Oncol       Date:  2018-09-17       Impact factor: 2.754

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.